Compare FCT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCT | TKNO |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.1M | 214.1M |
| IPO Year | N/A | 2021 |
| Metric | FCT | TKNO |
|---|---|---|
| Price | $9.99 | $3.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 106.8K | ★ 189.7K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 11.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,801,000.00 |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $10.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $9.45 | $3.60 |
| 52 Week High | $10.42 | $10.37 |
| Indicator | FCT | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 55.48 | 39.51 |
| Support Level | $9.93 | $3.75 |
| Resistance Level | $10.09 | $4.86 |
| Average True Range (ATR) | 0.06 | 0.30 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 28.77 | 31.23 |
First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.